APA (7th ed.) Citation

Marchioni, C., Santos-Lobato, B. L., Queiroz, M. E. C., Crippa, J. A. S., & Tumas, V. (2020). Endocannabinoid levels in patients with Parkinson’s disease with and without levodopa-induced dyskinesias. Journal of Neural Transmission: Translational Neuroscience, Neurology and Preclinical Neurological Studies, Psychiatry and Preclinical Psychiatric Studies, 127(10), 1359-1367. https://doi.org/10.1007/s00702-020-02240-9

Chicago Style (17th ed.) Citation

Marchioni, Camila, Bruno Lopes Santos-Lobato, Maria Eugênia Costa Queiroz, José Alexandre S. Crippa, and Vitor Tumas. "Endocannabinoid Levels in Patients with Parkinson’s Disease with and Without Levodopa-induced Dyskinesias." Journal of Neural Transmission: Translational Neuroscience, Neurology and Preclinical Neurological Studies, Psychiatry and Preclinical Psychiatric Studies 127, no. 10 (2020): 1359-1367. https://doi.org/10.1007/s00702-020-02240-9.

MLA (9th ed.) Citation

Marchioni, Camila, et al. "Endocannabinoid Levels in Patients with Parkinson’s Disease with and Without Levodopa-induced Dyskinesias." Journal of Neural Transmission: Translational Neuroscience, Neurology and Preclinical Neurological Studies, Psychiatry and Preclinical Psychiatric Studies, vol. 127, no. 10, 2020, pp. 1359-1367, https://doi.org/10.1007/s00702-020-02240-9.